DJIA 17,826.30 -279.47 -1.54%
NASDAQ 4,931.82 -75.98 -1.52%
S&P 500 2,081.18 -23.81 -1.13%
market minute promo

Abbott Laboratories (NYSE: ABT)

46.25 -0.27 (-0.58%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

ABT $46.25 -0.58%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $46.29
Previous Close $46.52
Daily Range $45.81 - $46.45
52-Week Range $37.78 - $47.88
Market Cap $69.8B
P/E Ratio 41.54
Dividend (Yield) $0.96 (2.1%)
Ex-Dividend Date
Dividend Pay Date
Volume 4,250,822
Average Daily Volume 4,693,838
Current FY EPS $2.15




Drug Makers

Abbott Laboratories (ABT) Description

Principal business is the discovery, development, manufacture and sale of a broad and diversified line of health care products. Company has four segments: Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Vascular Products. Website:

News & Commentary Rss Feed

Is AbbVie Inc. Stock About to Crash?

AbbVie has been an amazing growth story since its inception in 2013. However, this trend might be about to come to abrupt end. Here's why.

Rosetta Genomics Shares Upgraded At Cantor

Next Week In Biotech: Amgen, AbbVie, Biogen Earnings, UniQure CHMP, AAN Meeting

Notable ETF Outflow Detected - SSO, ABT, ABBV, ACN

Teva, Actavis, Other Generic Drugmakers May Be on Acquisition Trail

Abbott Labs, Sekisui Medical to Offer Coagulation Tests - Analyst Blog

Abbott Labs, Sekisui Medical to Offer Coagulation Tests - Analyst Blog

Taking A Financial Mulligan With Dividend Investing

Fast Money Picks For April 9: Disney, Yahoo, Nike, Abbott Labs

Options Traders in Abbott Labs Look for Another Quick Buck

Mylan Bids $29 Billion for Perrigo in Latest Big Pharma Deal

Can Perrigo Get More From Mylan?

See More ABT News...

ABT's Top Competitors

ABT $46.25 (-0.58%)
Current stock: ABT
JNJ $99.58 (-0.21%)
Current stock: JNJ
RHHBY $35.44 (-1.53%)
Current stock: RHHBY
PFE $35.04 (-0.43%)
Current stock: PFE